Transgenomic Inc. (Nasdaq: TBIO) launched its Transgenomic Leukodystrophy NGS Panel. Shares of the biotechnology company soared 51 cents to $1.94.
Transgenomic launches leukodystrophy NGS panel
July 14, 2015 at 13:19 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.